您搜索了: leucopenie (荷兰语 - 英语)

thrombocytopenie, leucopenie, eosinophilie
thrombocytopenia, leucopenia, eosinophilia

vaak: leucopenie (1.3% vs.
common: leucopenia (1.3% vs.

anemie, thrombocytopenie, leucopenie, leucocytose, thrombocythemie soms:
anaemia, thrombocytopenia, leukopenia, leukocytosis, thrombocytosis uncommon:

preventie van klinische symptomen, leucopenie en virusuitscheiding veroorzaakt door canine parvovirus,
to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,

bloed- en lymfestelselaandoeningen vaak: trombocytopenie, leucopenie, granulocytopenie soms: leucocytosis
blood and lymphatic system disorders common: thrombocytopenia, leucopenia, granulocytopenia uncommon: leukocytosis

preventie van klinische symptomen, leucopenie en virusuitscheiding veroorzaakt door canine parvo virus,
to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,

vaak: anemie, thrombocytopenie, leucopenie, leucocytose, thrombocythemie soms: aplastische anemie, ecchymose
common: anaemia, thrombocytopenia, leukopenia, leukocytosis, thrombocytosis uncommon: aplastic anaemia, ecchymosis

om die reden was er bij alle patiënten sprake van een ernstige cytopenie: leucopenie 96%, trombocytopenie 94% en anemie 88%.
therefore all patients experienced profound cytopenia: leucopenia 96%, thrombocytopenia 94%, and anemia 88%.

preventie van klinische symptomen, leucopenie en virusuitscheiding veroorzaakt door canine parvovirus, en preventie van klinische symptomen (neus- en ooguitvloeiing) en reductie van virusuitscheiding veroorzaakt door canine parainfluenzavirus
to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus, and to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus.

de meest voorkomende bijwerkingen van viraferon (waargenomen bij meer dan 1 op de 10 patiënten) zijn leucopenie (lage concentratie witte bloedcellen), anorexie (verlies van eetlust), depressie, nie
the most common side effects with viraferon in adults (seen in more than 1 patient in 10) are leucopenia (low white blood cell counts), anorexia (loss of appetite), depression, insomnia (difficulty lon sleeping), anxiety, agitation, nervousness, dizziness, headache, impaired concentration, dry mouth, blurred vision, nausea (feeling sick) or vomiting, abdominal (tummy) pain, diarrhoea, stomatitis (inflammation of the lining of the mouth), dyspepsia (indigestion), alopecia (hair loss), increased sweating, myalgia (muscle pain), arthralgia (joint pain), musculoskeletal pain (pain in the muscles and bones), inflammation at the site of the injection, fatigue (tiredness), rigors (shaking chills), fever, flu- no